EyePoint (EYPT) Gross Margin Growth (3y) (2021 - 2026)

EyePoint (EYPT) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -6,753.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -6,753.00
Dec 31, 2025 -2,811.00
Sep 30, 2025 -6,060.00
Jun 30, 2025 1,190.00
Mar 31, 2025 1,583.00
Dec 31, 2024 1,923.00
Sep 30, 2024 1,315.00
Jun 30, 2024 662.00
Mar 31, 2024 1,249.00
Dec 31, 2023 2,740.00
Sep 30, 2023 408.00
Jun 30, 2023 -750.00
Mar 31, 2023 476.00
Dec 31, 2022 -1,704.00
Sep 30, 2022 -100.00
Jun 30, 2022 -520.00
Mar 31, 2022 -272.00
Dec 31, 2021 -2,627.00
Sep 30, 2021 -2,015.00